Robert Gut

CIK: 0001716268

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (66.7%)

Position reduction

Option Exercises (M)3 (20.0%)

Derivative conversions

Awards (A)2 (13.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

QURE

uniQure N.V.

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

QURE
uniQure N.V.
Jun 11, 2026
Sale(S)
Direct
2.7K shares at avg. $27.06$74K
QURE
uniQure N.V.
Jun 10, 2026
Exercise(M)
Direct
2.6K shares at avg. $16.04$42K
QURE
uniQure N.V.
Jun 10, 2026
Sale(S)
Direct
2.6K shares at avg. $26.07$69K
QURE
uniQure N.V.
Jun 10, 2026
Sale(S)
Direct
3.1K shares at avg. $26.03$81K
QURE
uniQure N.V.
Jun 10, 2026
Sale(S)
Direct
1.8K shares at avg. $26.05$46K
QURE
uniQure N.V.
Jun 10, 2026
Award(A)
Direct
7.6K shares-
QURE
uniQure N.V.
Jan 12, 2026
Sale(S)
Direct
500 shares at avg. $25.03$13K
QURE
uniQure N.V.
Jan 12, 2026
Exercise(M)
Direct
17.8K shares at avg. $14.08$251K
QURE
uniQure N.V.
Jan 12, 2026
Sale(S)
Direct
17.3K shares at avg. $24.39$422K
QURE
uniQure N.V.
Jan 12, 2026
Sale(S)
Direct
7.8K shares at avg. $25.09$196K
QURE
uniQure N.V.
Nov 6, 2025
Sale(S)
Direct
15.8K shares at avg. $27.22$431K
QURE
uniQure N.V.
Nov 6, 2025
Exercise(M)
Direct
15.8K shares at avg. $4.57$72K
QURE
uniQure N.V.
Nov 6, 2025
Sale(S)
Direct
15.6K shares at avg. $27.30$426K
QURE
uniQure N.V.
Jun 20, 2025
Sale(S)
Direct
3.3K shares at avg. $14.45$48K
QURE
uniQure N.V.
Jun 11, 2025
Award(A)
Direct
8K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	QURE uniQure N.V.	Sale(S)	2,726	$27.06	$73,766	Direct
Jun 10, 2026	QURE uniQure N.V.	Exercise(M)	2,645	$16.04	$42,426	Direct
Jun 10, 2026	QURE uniQure N.V.	Sale(S)	2,645	$26.07	$68,955	Direct
Jun 10, 2026	QURE uniQure N.V.	Sale(S)	3,127	$26.03	$81,396	Direct
Jun 10, 2026	QURE uniQure N.V.	Sale(S)	1,780	$26.05	$46,369	Direct
Jun 10, 2026	QURE uniQure N.V.	Award(A)	7,550	-	$0	Direct
Jan 12, 2026	QURE uniQure N.V.	Sale(S)	500	$25.03	$12,515	Direct
Jan 12, 2026	QURE uniQure N.V.	Exercise(M)	17,810	$14.08	$250,765	Direct
Jan 12, 2026	QURE uniQure N.V.	Sale(S)	17,310	$24.39	$422,191	Direct
Jan 12, 2026	QURE uniQure N.V.	Sale(S)	7,803	$25.09	$195,777	Direct
Nov 6, 2025	QURE uniQure N.V.	Sale(S)	15,840	$27.22	$431,165	Direct
Nov 6, 2025	QURE uniQure N.V.	Exercise(M)	15,840	$4.57	$72,389	Direct
Nov 6, 2025	QURE uniQure N.V.	Sale(S)	15,594	$27.30	$425,716	Direct
Jun 20, 2025	QURE uniQure N.V.	Sale(S)	3,336	$14.45	$48,205	Direct
Jun 11, 2025	QURE uniQure N.V.	Award(A)	7,970	-	-	Direct

1-15 of 15 transactions

About Gut Robert

Gut Robert (SEC CIK 0001716268) files insider reports with the SEC as Director of uniQure N.V. (QURE).

Signal8 holds 5 ownership filings by Gut Robert, all Form 4s, filed between Jun 13, 2025 and Jun 12, 2026. Those filings report 15 transactions, from Jun 11, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gut Robert's filings is in AMSTERDAM.

Recent filings by Gut Robert

Jun 11, 2026: Open-market sale of QURE shares (Form 4, code S).
Jun 10, 2026: Option exercise of QURE shares (Form 4, code M).
Jun 10, 2026: Open-market sales of QURE shares (3 lines, Form 4, code S).
Jun 10, 2026: Grant or award of QURE shares (Form 4, code A).
Jan 12, 2026: Open-market sale of QURE shares (Form 4, code S).

Other insiders filing for uniQure N.V. (QURE)

Abi-Saab Walid, Chief Medical Officer
Kapusta Matthew C, CEO, Managing Director
Kaye Jack, Director
Balachandran Madhavan, Director
Potts Jeannette, Chief Legal Officer
Meek David D., Director

How to read Form 4 transaction codes